Skip to Content Facebook Feature Image

Japan's ruling party loses all 3 seats in special vote, seen as punishment for corruption scandal

News

Japan's ruling party loses all 3 seats in special vote, seen as punishment for corruption scandal
News

News

Japan's ruling party loses all 3 seats in special vote, seen as punishment for corruption scandal

2024-04-29 11:03 Last Updated At:11:20

TOKYO (AP) — Japan’s governing party, stung by an extensive slush funds scandal, lost all three seats in parliamentary by-elections Sunday in a major setback for Prime Minister Fumio Kishida in seeking reelection as his party's leader in the autumn.

The loss is considered punishment by voters for the Liberal Democratic Party scandal that erupted last year and has undermined Kishida’s leadership. The party’s loss of power is unlikely, however, because the opposition is fractured.

“The results were extremely severe,” LDP Secretary General Toshimitsu Motegi told reporters. “We humbly accept the severe results, and we will do our utmost to regain the trust from the public as we continue our effort to reform and tackle the challenges.”

The liberal-leaning main opposition Constitutional Democratic Party of Japan clinched all three seats in Shimane, Nagasaki and Tokyo, according to final vote counts posted on prefectural election committee websites.

The LDP previously held all three vacated seats. It did not field its own candidates in the Tokyo and Nagasaki by-elections because of the apparent low support for the party. It focused instead on defending the seat in the Shimane district that was vacated by the death of former LDP House Speaker Hiroyuki Hosoda, who was linked to a number of alleged irregularities, including the ongoing slush fund scandal.

Akiko Kamei, the CDPJ candidate who beat former Finance Ministry bureaucrat Norimasa Nishikori from the LDP in Shimane, said her victory in the district known as a “conservative kingdom” sent a big message to Kishida. “I believe the voters’ anger over LDP’s slush funds problem and the lack of improvement in daily lives in the prefecture became support for me,” she said.

CPDJ leader Kenta Izumi said the by-elections were about political reforms. “There are many voters across the country who also want to show (similar) views,” he said, adding that he will seek early national elections if reforms by the governing party are too slow.

The losses could reduce Kishida’s clout as LDP lawmakers may try to bring him down to put a new face ahead of the next general election. Such a move would dash Kishida’s hope for running in the party presidential race in September for another three-year term. As prime minister, he can call a snap election any time before the current term for the lower house expires in October 2025.

Kishida has fought plummeting support ratings since the corruption scandal erupted last year. He has removed a number of Cabinet ministers and others from party executive posts, conducted internal hearings and drafted reform measures, but support ratings for his government have dwindled to around 20%.

The scandal centers on unreported political funds raised through tickets sold for party events. Ten people — lawmakers and their aides — were indicted in January.

More than 80 governing party lawmakers, most of them belonging to a major party faction previously led by assassinated former Prime Minister Shinzo Abe, have acknowledged not reporting funds in a possible violation of the Political Funds Control Law. The money received from the long-term practice is alleged to have gone into unmonitored slush funds.

Japanese Prime Minister and leader of the Liberal Democratic Party Fumio Kishida makes a speech on the final day of an election campaign for parliamentary by-elections, in Matsue, Shimane prefecture, western Japan Saturday, April 27, 2024. Japan’s governing party, stung by an extensive slush funds scandal, lost all three seats in parliamentary by-elections Sunday in a major setback for Kishida in seeking reelection as his party's leader in the autumn. (Kyodo News via AP)

Japanese Prime Minister and leader of the Liberal Democratic Party Fumio Kishida makes a speech on the final day of an election campaign for parliamentary by-elections, in Matsue, Shimane prefecture, western Japan Saturday, April 27, 2024. Japan’s governing party, stung by an extensive slush funds scandal, lost all three seats in parliamentary by-elections Sunday in a major setback for Kishida in seeking reelection as his party's leader in the autumn. (Kyodo News via AP)

Japan's governing party, Liberal Democratic Party’s Secretary General Toshimitsu Motegi speak to reporters at the party's headquarters in Tokyo Sunday, April 28, 2024. Japan’s governing party, stung by an extensive slush funds scandal, lost all three seats in parliamentary by-elections Sunday in a major setback for Prime Minister Fumio Kishida in seeking reelection as his party's leader in the autumn. (Kyodo News via AP)

Japan's governing party, Liberal Democratic Party’s Secretary General Toshimitsu Motegi speak to reporters at the party's headquarters in Tokyo Sunday, April 28, 2024. Japan’s governing party, stung by an extensive slush funds scandal, lost all three seats in parliamentary by-elections Sunday in a major setback for Prime Minister Fumio Kishida in seeking reelection as his party's leader in the autumn. (Kyodo News via AP)

SAN DIEGO--(BUSINESS WIRE)--May 15, 2024--

IntelliGuard, a fast-growing provider of medication management and data intelligence solutions, announces the appointment of Rob Sobie as Chief Product Officer. This addition strengthens IntelliGuard’s executive team and further elevates the company’s mission to drive innovative solutions centered around creating an environment of safety for health systems and patients.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240515332383/en/

Rob brings a wealth of knowledge, boasting an impressive three-decade tenure in product development, strategic planning, and executive leadership within the healthcare sector. His expertise has been pivotal in steering teams towards the successful launch of revolutionary products that have set new benchmarks in the industry. Rob has held senior, executive-level roles with Cardinal Health, BD Pyxis, CareFusion, InterMetro, CUBEX, and ARC Healthcare Technologies and is poised to make a significant impact at IntelliGuard. In his role as Chief Product Officer, Rob will be responsible for overseeing all aspects of product management, from conceptualization to execution. His strong technical background, sales and marketing experience, and visionary leadership style will be instrumental to deliver value to IntelliGuard’s customers and the patients they serve.

“Rob’s strategic leadership and guidance will be critical in shaping the direction of our product roadmap and ensuring that we continue to deliver exceptional value to our customers,” said Tim Tinnel, Chief Operating Officer. “His expertise will undoubtedly drive IntelliGuard’s growth and innovation to new heights to provide enhanced healthcare solutions that ultimately create an environment of safety for all of our customers.”

“I am absolutely thrilled to become a member of the IntelliGuard family, a company that stands at the forefront of innovation and thought leadership,” said Sobie. “The opportunity to contribute to their mission of transforming the healthcare medication management process is incredibly exciting as their unwavering commitment and unique approach set them apart in the industry. With an ever-growing ecosystem of interconnected products and services, they are uniquely positioned to enhance operational efficiency, safeguard patients and staff, and bolster financial performance. I look forward to playing a pivotal role in this journey and driving forward our shared vision for a safer, more efficient healthcare system.”

About IntelliGuard

IntelliGuard is a provider of medication management systems to track, trace, and manage medications and critical inventory. Through its flagship RFID-based system, IntelliGuard protects patients and hospitals by creating an environment of safety around every medication decision from supplier to patient with greater than 99% levels of accuracy. IntelliGuard enables better medication management compliance, visibility, and guidance throughout the medication journey and reassurance for key decision-makers in pharmacy, operations, and anesthesiology that necessary guardrails are in place to ensure patient safety. For more information, visit IntelliGuard.

Rob Sobie, Chief Product Officer, IntelliGuard (Photo: Business Wire)

Rob Sobie, Chief Product Officer, IntelliGuard (Photo: Business Wire)

Recommended Articles